Priya Menon
Industrials & Aerospace Analyst
Articles 727
OpenAI Introduces ChatGPT Health to Assist Patients and Clinicians Amidst Healthcare Challenges
AI flags critical drug interaction overlooked by physicians, raising questions on data privacy and reliability
OpenAI recently launched ChatGPT Health, an AI-driven tool aimed at simplifying complex medical information for both patients and healthcare providers...
Jim Mellon Foresees Protracted Recovery for Venezuelan Oil Yet Highlights U.S. Refiners' Potential Gains
Investor urges increased stakes in oil and gas amid complex Venezuelan production outlook and U.S. market dynamics
Investor Jim Mellon underscores a lengthy recovery timeline for Venezuela's oil output, anticipating a rebound to 3 million barrels per day within 5 t...
Johnson & Johnson Agrees to Drug Price Reductions to Secure Tariff Exemptions
Pharma giant commits to making medicines more affordable while expanding U.S. manufacturing investments
Johnson & Johnson has reached an agreement with U.S. authorities to reduce the cost of its pharmaceuticals available to American consumers in exchange...
Merck Pursues Acquisition of Revolution Medicines in Potential $28-$32 Billion Deal
Deal Could Mark a Significant Expansion in Merck’s Oncology Portfolio Amidst Industry Patent Challenges
Merck & Co. is reportedly engaged in negotiations to acquire Revolution Medicines, a cancer-focused biotechnology firm, in a transaction valued betwee...
December Shows Minimal Job Growth Amid Stagnant Labor Market in 2023
Unemployment Rate Edges Down to 4.4%, Marking the First Decrease Since Mid-Year
The U.S. labor market closed 2023 with disappointing employment growth, as December saw employers add only 50,000 jobs. While job creation remained sl...
Congresswoman Lisa McClain Invests Significant Capital in Elon Musk's Private AI Firm xAI
The Funding Round Elevates xAI’s Valuation Beyond $200 Billion as McClain Joins a Select Group of Investors
Elon Musk's AI venture, xAI, has successfully raised $20 billion during its Series E funding round, valuing the company at over $200 billion. Among th...
Trump's Approval Declines Following Venezuelan Military Action: Foreign Policy Assessment Worsens
Voter sentiment cools as U.S. intervention in Venezuela sparks fresh concerns over executive leadership and future foreign engagements
President Donald Trump's approval rating has dipped below 50% in early 2026, according to a new Morning Consult poll conducted prior to public confirm...
New Federal Nutrition Guidelines May Drive Family Grocery Expenses Above $36,000 Annually
Robert F. Kennedy Jr.'s Dietary Framework Signals Market Shifts for Food Industry Leaders
Health and Human Services Secretary Robert F. Kennedy Jr. introduced revised federal nutrition guidelines favoring protein-rich and minimally processe...
Congressional Budget Office Forecasts Fed Rate Cuts in 2026 and Rising Treasury Yields
Economic Projections Highlight Impact of Fiscal Policies and Immigration on Growth and Inflation
The Congressional Budget Office projects that the Federal Reserve will lower short-term interest rates in 2026, with rates stabilizing near 3.4% by 20...
Compass Pathways: High-Reward Psychedelic Bet, But Watch the Balance Sheet
Clinical promise for psilocybin therapy meets a stretched balance sheet - trade as a catalyst-driven, high-risk long
COMPASS Pathways (CMPS) is one of the better-known pioneers in psilocybin therapy for treatment-resistant depression. The company has clinical momentu...